Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
0.4389
+0.0290 (7.07%)
At close: Feb 27, 2026, 4:00 PM EST
0.4400
+0.0011 (0.25%)
After-hours: Feb 27, 2026, 7:59 PM EST
Autonomix Medical Employees
As of March 31, 2025, Autonomix Medical had 11 total employees, including 8 full-time and 3 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$1,567,273
Market Cap
5.01M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 11 | 3 | 37.50% | 8 | 3 |
| Mar 31, 2024 | 8 | 4 | 100.00% | 5 | 3 |
| Mar 31, 2023 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Intelligent Bio Solutions | 55 |
| Biomerica | 54 |
| Nuwellis | 38 |
| enVVeno Medical | 37 |
| ENvue Medical | 31 |
| Tenon Medical | 27 |
| Catheter Precision | 22 |
| HeartSciences | 15 |
AMIX News
- 4 days ago - Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation - GlobeNewsWire
- 10 days ago - Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation - GlobeNewsWire
- 7 weeks ago - Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - GlobeNewsWire
- 2 months ago - Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - GlobeNewsWire
- 2 months ago - Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium - GlobeNewsWire
- 3 months ago - Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth - GlobeNewsWire
- 4 months ago - Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference - GlobeNewsWire
- 4 months ago - Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit - GlobeNewsWire